33 related articles for article (PubMed ID: 11162568)
1. Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts.
Turner DGP; De Lange WJ; Zhu Y; Coe CL; Simcox J; Ge Y; Kamp TJ; Ralphe JC; Glukhov AV
J Physiol; 2023 Oct; ():. PubMed ID: 37889115
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2).
Yi J; Qi B; Yin J; Li R; Chen X; Hu J; Li G; Zhang S; Zhang Y; Yang M
Nat Commun; 2023 Nov; 14(1):7755. PubMed ID: 38012235
[TBL] [Abstract][Full Text] [Related]
3. Impact of HepG2 Cells Glutathione Depletion on Neutral Sphingomyelinases mRNA Levels and Activity.
Gamal M; Tallima H; Azzazy HME; Abdelnaser A
Curr Issues Mol Biol; 2023 Jun; 45(6):5005-5017. PubMed ID: 37367067
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling.
Yabu T; Shiba H; Shibasaki Y; Nakanishi T; Imamura S; Touhata K; Yamashita M
Cell Death Differ; 2015 Feb; 22(2):258-73. PubMed ID: 25168245
[TBL] [Abstract][Full Text] [Related]
6. The roles of neutral sphingomyelinases in neurological pathologies.
Horres CR; Hannun YA
Neurochem Res; 2012 Jun; 37(6):1137-49. PubMed ID: 22237969
[TBL] [Abstract][Full Text] [Related]
7. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
8. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
Yabu T; Imamura S; Yamashita M; Okazaki T
J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
[TBL] [Abstract][Full Text] [Related]
9. Ceramide: second messenger or modulator of membrane structure and dynamics?
van Blitterswijk WJ; van der Luit AH; Veldman RJ; Verheij M; Borst J
Biochem J; 2003 Jan; 369(Pt 2):199-211. PubMed ID: 12408751
[TBL] [Abstract][Full Text] [Related]
10. Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stress.
Fensome AC; Josephs M; Katan M; Rodrigues-Lima F
Biochem J; 2002 Jul; 365(Pt 1):69-77. PubMed ID: 12071841
[TBL] [Abstract][Full Text] [Related]
11. Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease.
Zumbansen M; Stoffel W
Mol Cell Biol; 2002 Jun; 22(11):3633-8. PubMed ID: 11997500
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2.
Goswami R; Ahmed M; Kilkus J; Han T; Dawson SA; Dawson G
J Neurosci Res; 2005 Jul; 81(2):208-17. PubMed ID: 15929065
[TBL] [Abstract][Full Text] [Related]
13. Influence of L-carnitine on CD95 cross-lining-induced apoptosis and ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral sphingomyelinases in vitro.
Di Marzio L; Alesse E; Roncaioli P; Muzi P; Moretti S; Marcellini S; Amicosante G; De Simone C; Cifone MG
Proc Assoc Am Physicians; 1997 Mar; 109(2):154-63. PubMed ID: 9069584
[TBL] [Abstract][Full Text] [Related]
14. Ceramide-induced cell death in malignant cells.
Carpinteiro A; Dumitru C; Schenck M; Gulbins E
Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
[TBL] [Abstract][Full Text] [Related]
15. Biological aspects of ceramide-enriched membrane domains.
Grassmé H; Riethmüller J; Gulbins E
Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
[TBL] [Abstract][Full Text] [Related]
16. Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis.
Tepper AD; Ruurs P; Borst J; van Blitterswijk WJ
Biochem Biophys Res Commun; 2001 Jan; 280(3):634-9. PubMed ID: 11162568
[TBL] [Abstract][Full Text] [Related]
17. Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide.
Lin M; Liao W; Dong M; Zhu R; Xiao J; Sun T; Chen Z; Wu B; Jin J
FEBS J; 2018 Oct; 285(20):3835-3848. PubMed ID: 30106227
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
